Caribou Biosciences Inc CRBU:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:35 PM EDT
9.30UNCH (UNCH)
Volume
2,538,601
Close
9.30quote price arrow up+1.16 (+14.25%)
Volume
851,892
52 week range
4.89 - 32.65
Loading...
  • Open8.11
  • Day High9.36
  • Day Low7.85
  • Prev Close8.14
  • 52 Week High32.65
  • 52 Week High Date09/07/21
  • 52 Week Low4.89
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap564.60M
  • Shares Out60.71M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.37

KEY STATS

  • Open8.11
  • Day High9.36
  • Day Low7.85
  • Prev Close8.14
  • 52 Week High32.65
  • 52 Week High Date09/07/21
  • 52 Week Low4.89
  • 52 Week Low Date06/16/22
  • Market Cap564.60M
  • Shares Out60.71M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-38.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.47
  • P/E (TTM)-3.76
  • Fwd P/E (NTM)-6.01
  • EBITDA (TTM)-74.70M
  • ROE (TTM)-43.35%
  • Revenue (TTM)10.68M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-682.39%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/09/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Caribou Biosciences Inc

There is no recent news for this security.

Profile

MORE
Caribou Biosciences, Inc. is a clinical-stage genome-editing biopharmaceutical company. The Company is developing transformative clustered regularly interspaced short palindromic repeats (CRISPR) therapies for patients with devastating diseases. The Company’s CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), enables superior genome-editing precision to develop cell therapies that are specifically engineered for enhanced persistence. It is advancing a pipeline of allogeneic, or...
Rachel Haurwitz Ph.D.
President, Chief Executive Officer, Co-Founder, Director
Jason O'byrne
Chief Financial Officer
Address
2929 7TH STREET, STE 120
Berkeley, CA
94710
United States

Top Peers

SYMBOLLASTCHG%CHG
RPTX
Repare Therapeutics Inc
12.73+0.80+6.71%
VXRT
Vaxart Inc
4.46+0.21+4.94%
AKRO
Akero Therapeutics Inc
13.74+0.86+6.68%
ALT
Altimmune Inc
12.86+0.53+4.30%
CNTA
Centessa Pharmaceuticals PLC
4.75-0.26-5.19%